Document is current
Any future updates will be listed below
-
Authors
Godoy-González, Marta
López-Aguilar, Josefina
Fernández-Gonzalo, Sol
Gomà, Gemma
Blanch, Lluís
Brandi, Santiago
Ramírez, Sergi
Blasi, Joel
Verschure, Paul
Rialp, Gemma
Roca, Miquel
Gili, Margalida
Jodar, Mercè
Navarra-Ventura, Guillem
-
Funding
Funding for this research was provided by:
CIBERES, ISCIII (CB06/06/1097)
ACCIO Nuclis d'R+D empresarial (RD17-1-0015)
Marató de TV3 (202223-10 (160/U/2022))
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 2 December 2024
First Online: 18 December 2024
Declarations
:
: All procedures contributing to this trial comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. Ethical approval has been provided by the Ethics Committee of the Balearic Islands (Ref. IB 5329/23 PI) and by the Ethics Committee of the Parc Taulí University Hospital (Ref. 2022/3030): protocol version 2 of September 12, 2023. Written informed consent will be obtained from all participants.
: Not applicable.
: J.L.A., S.F.G., L.B., M.J. and G.N.V. are inventors of the ENRIC platform. M.G.G., J.L.A., S.F.G., M.J. and G.N.V. are inventors of the RGS-ICU platform, whose intellectual property is shared with Eodyne Systems S.L. P.V. declares to be the founder and shareholder of Eodyne Systems S.L. The other authors declare that they have no competing interests.
